Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Cell Pathways
is defunct.
Acquired by OSI Pharmaceuticals, Feb 2003, $32M
------------------
If you believe any of this information is incorrect, please
let us know
.